Loading
₹1,682.00
−10.80−0.64%today
Market closed · 7 Oct, 3:30 pm
+54.30%over 1 year
Today's range
₹1,670.50₹1,698.90
52-week range
₹1,066.80₹1,740.00
Revenue and net profit in ₹ crore, consolidated where the company reports both.
| Year | Revenue | Net profit | Margin | EPS (₹) |
|---|---|---|---|---|
| FY26 | 33,385 | 3,505 | 10.5% | 60.34 |
| FY25 | 31,378 | 3,486 | 11.1% | 59.81 |
| FY24 | 28,705 | 3,173 | 11.1% | 54.16 |
| FY23 | 24,617 | 1,928 | 7.8% | 32.90 |
As of Jun 2026, as a share of all the company's shares.
| Holder | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 51.88% | 51.82% | 51.82% | 51.82% |
| FIIs | 16.38% | 15.24% | 13.94% | 14.21% |
| DIIs | 25.10% | 25.87% | 27.68% | 27.60% |
| of which mutual funds | 16.71% | 17.79% | 19.52% | 19.30% |
| Public | 6.64% | 7.08% | 6.55% | 6.38% |
From the company's quarterly filings with NSE. FIIs are foreign institutions; DIIs are Indian ones such as mutual funds, insurers and banks.
Healthcare companies in the Nifty 500 closest in size.
| Company | Price (₹) | Change | Market cap (₹ cr) |
|---|---|---|---|
| Laurus Labs Ltd.LAURUSLABS | 2,052.80 | +0.14% | 1,10,915 |
| Cipla Ltd.CIPLA | 1,327.20 | −0.97% | 1,07,221 |
| Mankind Pharma Ltd.MANKIND | 2,500.00 | 0.00% | 1,03,261 |
| Dr. Reddy's Laboratories Ltd.DRREDDY | 1,203.80 | −0.35% | 1,00,476 |
| Aurobindo Pharma Ltd.AUROPHARMA · this stock | 1,682.00 | −0.64% | 96,779 |
| Lupin Ltd.LUPIN | 2,012.90 | −0.81% | 92,048 |
| Max Healthcare Institute Ltd.MAXHEALTH | 908.00 | +0.61% | 88,377 |
Price and volume from NSE; key figures and results from Yahoo Finance; shareholding and corporate actions from the company's NSE filings. Figures can run behind the exchange. For information only, not a recommendation to invest.